Soliton Appoints Dr. Sachin Shridharani to Scientific Advisory Board
HOUSTON, Aug. 5, 2020 /PRNewswire/ --Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Dr. Sachin Shridharani to its Scientific Advisory Board, effective immediately.
- HOUSTON, Aug. 5, 2020 /PRNewswire/ --Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Dr. Sachin Shridharani to its Scientific Advisory Board, effective immediately.
- "Dr. Shridharani is an extremely talented and accomplished medical professional, and we are elated to have him join our Scientific Advisory Board.
- "There is a significant unmet demand for a noninvasive, painless treatment for cellulite that is effective and has no bruising and minimal to no patient downtime," commented Dr. Shridharani.
- Join our more than 200K subscribers here to follow the Company: https://soly-investors.com
Dr. Sachin M. Shridharani is a renowned, Manhattan-based plastic surgeon, board certified by The American Board of Plastic Surgery and founder of LUXURGERY the confluence of luxury and aesthetic surgery.